SemOpenAlex |

SemOpenAlex

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2995012900> ?p ?o ?g. }

Showing items 1 to 100 of ±200 with 100 items per page.

W2995012900 endingPage "7" @default.
W2995012900 startingPage "1" @default.
W2995012900 abstract "Background and Aims: Chronic hepatitis B virus (HBV) infection remains a major public health problem globally. Here, we describe the baseline characteristics and treatment profiles of HBV-infected patients recruited to the China Registry of Hepatitis B. Methods: Inclusion criteria were patients with different stages of chronic HBV infection and complete key data. Exclusion criteria were patients with hepatocellular carcinoma. The baseline clinical, laboratory and treatment profiles were analyzed. Results: Finally, 40,431 patients were included. The median age was 43 years, with 65.2% being men and 51.3% being positive for hepatitis B e antigen (HBeAg). The most common initial diagnosis was chronic hepatitis B (81.0%), followed by cirrhosis (9.3%), inactive carrier of hepatitis B surface antigen (HBsAg) (6.7%), and immune tolerant phase of hepatitis B infection (3.0%). Among the 21,228 patients who were on treatment, 88.0%, 10.0% and 2.0% received nucleos(t)ide analogues (NAs), interferon or combination of NAs and interferon, respectively. The proportion of patients who received preferred NAs (entecavir or tenofovir disoproxil fumarate) had increased from 13.5% in 2003 to 79.7% in 2016. Conclusions: We concluded that middle-aged men accounted for most of the patients with chronic hepatitis B in this cross-sectional study. About half of the patients were HBeAg-positive. NAs were the most commonly used therapy, and use of the preferred NAs had steadily increased in the past decade." @default.
W2995012900 created "2019-12-26" @default.
W2995012900 creator A5001024551 @default.
W2995012900 creator A5002405018 @default.
W2995012900 creator A5003016237 @default.
W2995012900 creator A5003759585 @default.
W2995012900 creator A5005215654 @default.
W2995012900 creator A5005542093 @default.
W2995012900 creator A5006320858 @default.
W2995012900 creator A5007991562 @default.
W2995012900 creator A5008566878 @default.
W2995012900 creator A5008949726 @default.
W2995012900 creator A5009555060 @default.
W2995012900 creator A5010381174 @default.
W2995012900 creator A5011275179 @default.
W2995012900 creator A5012108815 @default.
W2995012900 creator A5014268039 @default.
W2995012900 creator A5015716640 @default.
W2995012900 creator A5016396916 @default.
W2995012900 creator A5019237114 @default.
W2995012900 creator A5026919394 @default.
W2995012900 creator A5032092961 @default.
W2995012900 creator A5034168127 @default.
W2995012900 creator A5034482568 @default.
W2995012900 creator A5034745150 @default.
W2995012900 creator A5035169366 @default.
W2995012900 creator A5036143268 @default.
W2995012900 creator A5039773936 @default.
W2995012900 creator A5040485869 @default.
W2995012900 creator A5043785375 @default.
W2995012900 creator A5050491740 @default.
W2995012900 creator A5051385074 @default.
W2995012900 creator A5052998000 @default.
W2995012900 creator A5053769309 @default.
W2995012900 creator A5053894247 @default.
W2995012900 creator A5056241757 @default.
W2995012900 creator A5063789000 @default.
W2995012900 creator A5066251595 @default.
W2995012900 creator A5066330334 @default.
W2995012900 creator A5066884099 @default.
W2995012900 creator A5068361652 @default.
W2995012900 creator A5069190300 @default.
W2995012900 creator A5071878508 @default.
W2995012900 creator A5072354292 @default.
W2995012900 creator A5073649443 @default.
W2995012900 creator A5074087343 @default.
W2995012900 creator A5077471484 @default.
W2995012900 creator A5078653034 @default.
W2995012900 creator A5078788929 @default.
W2995012900 creator A5079858305 @default.
W2995012900 creator A5088981302 @default.
W2995012900 creator A5089865739 @default.
W2995012900 creator A5090536107 @default.
W2995012900 creator A5090903647 @default.
W2995012900 creator A5091732199 @default.
W2995012900 date "2019-12-20" @default.
W2995012900 modified "2023-10-14" @default.
W2995012900 title "Baseline Characteristics and Treatment Patterns of the Patients Recruited to the China Registry of Hepatitis B" @default.
W2995012900 cites W1154584763 @default.
W2995012900 cites W1799522345 @default.
W2995012900 cites W2012824806 @default.
W2995012900 cites W2048516298 @default.
W2995012900 cites W2053065584 @default.
W2995012900 cites W2067109440 @default.
W2995012900 cites W2089145440 @default.
W2995012900 cites W2155510029 @default.
W2995012900 cites W2168630917 @default.
W2995012900 cites W2174723704 @default.
W2995012900 cites W2290533728 @default.
W2995012900 cites W2442985902 @default.
W2995012900 cites W2462340700 @default.
W2995012900 cites W2468525331 @default.
W2995012900 cites W2521491190 @default.
W2995012900 cites W2527401856 @default.
W2995012900 cites W2567594783 @default.
W2995012900 cites W2589531091 @default.
W2995012900 cites W2605785536 @default.
W2995012900 cites W2767871131 @default.
W2995012900 cites W2767893465 @default.
W2995012900 cites W2768065696 @default.
W2995012900 cites W2789542186 @default.
W2995012900 cites W2791839818 @default.
W2995012900 cites W2799830486 @default.
W2995012900 cites W4253457069 @default.
W2995012900 doi "https://doi.org/10.14218/jcth.2019.00052" @default.
W2995012900 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6943209" @default.
W2995012900 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31915601" @default.
W2995012900 hasPublicationYear "2019" @default.
W2995012900 type Work @default.
W2995012900 sameAs 2995012900 @default.
W2995012900 citedByCount "7" @default.
W2995012900 countsByYear W29950129002022 @default.
W2995012900 countsByYear W29950129002023 @default.
W2995012900 crossrefType "journal-article" @default.
W2995012900 hasAuthorship W2995012900A5001024551 @default.
W2995012900 hasAuthorship W2995012900A5002405018 @default.
W2995012900 hasAuthorship W2995012900A5003016237 @default.
W2995012900 hasAuthorship W2995012900A5003759585 @default.